Observe Medical ASA – Doctoral dissertation further demonstrates clinical benefits of Sippi®

The PhD thesis ‘Evaluation of an automatic urinometer including use of silicone oil to decrease biofilm formation due to proteinuria, hemoglobinuria and bacterial growth’ is written by Dr. Martin Slettengren and was dissertated at Dept. of Molecular Medicine and Surgery, Karolinska Institute in Stockholm on January 14, 2021. One of the studies in the thesis was announced in Observe Medical’s release August 17, 2021.

“My thesis shows that the Sippi automatic diuresis measurement system is clearly more appreciated by ward personnel than current manual systems, as it saves them time, is ergonomically superior, and measures diuresis as correct as or better than the manual systems. Accurate monitoring of diuresis is key to detect emerging kidney failure and fluid balance distortions. The ability to monitor trends in diuresis in more detail, combined with the superior usability of the Sippi system, is an important step in improving patient safety in this respect,” says Dr. Martin Slettengren.

Dr. Slettengren’s study also shows that silicone oil (Sippcoat®) reduces growth of microbial biofilm formation as well as biofilm coating from albumin and free hemoglobin.

“This improves the performance of the Sippi device substantially and enables it to function for patients with on-going urinary tract infection, albuminuria and hemoglobinuria. Finally, the Sippi detection system (SippSense®) may provide new information for early warning of kidney disease, which could be an indicator for need of clinical preventive actions,” Dr. Slettengren says.

Observe Medical is currently launching Sippi® automated digital urine meter in selected markets in Europe, with the near-term focus on accelerating Sippi® clinical use in the Nordics.

“The pandemic is highlighting key clinical challenges, not the least concerning urine measurement at ICUs and other hospital departments. The recent work by Dr. Martin Slettengren is adding to previous evidence, and further validating Sippi® relevance addressing the key clinical challenges of urine measurement,” says Björn Larsson, CEO of Observe Medical, and continues:

 “We are excited to move into 2021 with full speed and force, strengthened by the findings from the recent work by Dr. Slettengren which further validates the clinical benefits of the Sippi® system.”

Link to Karolinska Instititutet’s summary of the thesis: https://nyheter.ki.se/ny-avhandling-utvarderar-automatisk-urinmatare-hos-postoperativa-patienter